Daniel J. Slade
AstraZeneca (United Kingdom)(GB)AstraZeneca (Singapore)(SG)AstraZeneca (Germany)(DE)Virginia Tech(US)
Publications by Year
Research Areas
Gut microbiota and health, Oral microbiology and periodontitis research, Streptococcal Infections and Treatments, Otolaryngology and Infectious Diseases, Cell Adhesion Molecules Research
Most-Cited Works
- → Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation(2015)735 cited
- → Activation of PAD4 in NET formation(2012)387 cited
- → Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration(2020)307 cited
- → The gut microbial metabolite formate exacerbates colorectal cancer progression(2022)284 cited
- → The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View(2020)264 cited
- → Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation(2012)207 cited